VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $105,756 | -10.6% | 3,930 | 0.0% | 0.07% | -6.9% |
Q2 2023 | $118,332 | -6.9% | 3,930 | 0.0% | 0.07% | -12.2% |
Q1 2023 | $127,136 | +12.9% | 3,930 | 0.0% | 0.08% | +5.1% |
Q4 2022 | $112,634 | +18.8% | 3,930 | 0.0% | 0.08% | +8.3% |
Q3 2022 | $94,792 | -11.9% | 3,930 | 0.0% | 0.07% | -6.5% |
Q2 2022 | $107,603 | -28.7% | 3,930 | 0.0% | 0.08% | -17.2% |
Q1 2022 | $151,000 | +19.8% | 3,930 | 0.0% | 0.09% | +22.4% |
Q4 2021 | $126,000 | +8.6% | 3,930 | 0.0% | 0.08% | -3.8% |
Q3 2021 | $116,000 | -13.4% | 3,930 | 0.0% | 0.08% | -13.2% |
Q2 2021 | $134,000 | +4.7% | 3,930 | 0.0% | 0.09% | -3.2% |
Q1 2021 | $128,000 | -9.9% | 3,930 | 0.0% | 0.09% | -13.0% |
Q4 2020 | $142,000 | -7.8% | 3,930 | 0.0% | 0.11% | -19.4% |
Q3 2020 | $154,000 | +6.9% | 3,930 | 0.0% | 0.13% | -0.7% |
Q2 2020 | $144,000 | +38.5% | 3,930 | -13.1% | 0.14% | +12.5% |
Q1 2020 | $104,000 | -21.2% | 4,525 | 0.0% | 0.12% | -7.0% |
Q4 2019 | $132,000 | – | 4,525 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |